Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 6/20 | 0.45 |
| ▸ | GSTM2 | P28161 | 6/20 | 0.45 |
| ▸ | MYC | P01106 | 5/20 | 0.45 |
| ▸ | MAX | P61244 | 3/20 | 0.45 |
| ▸ | IDO1 | P14902 | 6/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | TDO2 | P48775 | 4/20 | 0.41 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31589361 | 0.95 | IDO1 (0.45) | GSTP1GSTM2MYCMAXIDO1 | |
| SCHEMBL31589421 | 0.89 | IDO1 (0.48) | GSTP1GSTM2MYCMAXIDO1 | |
| SCHEMBL31589214 | 0.87 | MEN1 (0.41) | GSTP1GSTM2MYCMAXIDO1 | |
| SCHEMBL31590065 | 0.87 | IDO1 (0.43) | GSTP1GSTM2MYCIDO1MEN1 | |
| SCHEMBL31589566 | 0.86 | IDO1 (0.37) | GSTP1GSTM2MYCMAXIDO1 | |
| SCHEMBL31589177 | 0.86 | GSTP1 (0.40) | GSTP1GSTM2MYCMAXIDO1 | |
| SCHEMBL31589348 | 0.86 | MEN1 (0.42) | GSTP1GSTM2MYCMAXIDO1 | |
| SCHEMBL31589556 | 0.85 | IDO1 (0.42) | GSTP1GSTM2MYCIDO1MEN1 | |
| SCHEMBL31590089 | 0.85 | MEN1 (0.40) | GSTP1GSTM2MYCMAXIDO1 | |
| SCHEMBL31589495 | 0.85 | IDO1 (0.40) | GSTP1GSTM2MYCIDO1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040371-A | Compound capable of degrading MYC in targeted manner and application thereof | 中国医学科学院医药生物技术研究所 | 2025-05-27 | — | — | CN | disclosed |